Literature DB >> 27852786

Electrophysiological Evidence for Alternative Motor Networks in REM Sleep Behavior Disorder.

Marc Hackius1, Esther Werth1, Oguzkan Sürücü2, Christian R Baumann1, Lukas L Imbach3.   

Abstract

Patients with Parkinson's disease (PD) and REM sleep behavior disorder (RBD) show mostly unimpaired motor behavior during REM sleep, which contrasts strongly to coexistent nocturnal bradykinesia. The reason for this sudden amelioration of motor control in REM sleep is unknown, however. We set out to determine whether movements during REM sleep are processed by different motor networks than movements in the waking state. We recorded local field potentials in the subthalamic nucleus (STN) and scalp EEG (modified 10/20 montage) during sleep in humans with PD and RBD. Time-locked event-related β band oscillations were calculated during movements in REM sleep compared with movements in the waking state and during NREM sleep. Spectral analysis of STN local field potentials revealed elevated β power during REM sleep compared with NREM sleep and β power in REM sleep reached levels similar as in the waking state. Event-related analysis showed time-locked β desynchronization during WAKE movements. In contrast, we found significantly elevated β activity before and during movements in REM sleep and NREM sleep. Corticosubthalamic coherence was reduced during REM and NREM movements. We conclude that sleep-related movements are not processed by the same corticobasal ganglia network as movements in the waking state. Therefore, the well-known seemingly normal motor performance during RBD in PD patients might be generated by activating alternative motor networks for movement initiation. These findings support the hypothesis that pathological movement-inhibiting basal ganglia networks in PD patients are bypassed during sleep. SIGNIFICANCE STATEMENT: This study provides evidence that nocturnal movements during REM sleep in Parkinson's disease (PD) patients are not processed by the same corticobasal ganglia network as movements in the waking state. This implicates the existence of an alternative motor network that does not depend directly on the availability of l-Dopa in the basal ganglia. These findings further indicate that some PD patients are able to perform movements in the dopamine depleted state, possibly by bypassing the pathological basal ganglia network. The existence and direct activation of such alternative motor networks might finally have potential therapeutic effects for PD patients.
Copyright © 2016 the authors 0270-6474/16/3611795-06$15.00/0.

Entities:  

Keywords:  Parkinson's disease; REM sleep behavior disorder; sleep; subthalamic nucleus; β oscillations

Mesh:

Year:  2016        PMID: 27852786      PMCID: PMC6705633          DOI: 10.1523/JNEUROSCI.2546-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  4 in total

Review 1.  Sleep-wake and circadian disturbances in Parkinson disease: a short clinical guide.

Authors:  Christian R Baumann
Journal:  J Neural Transm (Vienna)       Date:  2019-06-29       Impact factor: 3.575

2.  Automatic Sleep Stage Classification Based on Subthalamic Local Field Potentials.

Authors:  Yue Chen; Chen Gong; Hongwei Hao; Yi Guo; Shujun Xu; Yuhuan Zhang; Guoping Yin; Xin Cao; Anchao Yang; Fangang Meng; Jingying Ye; Hesheng Liu; Jianguo Zhang; Yanan Sui; Luming Li
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2019-01-01       Impact factor: 3.802

3.  Basal ganglia engagement during REM sleep movements in Parkinson's disease.

Authors:  Ajay K Verma; Sergio Francisco Acosta Lenis; Joshua E Aman; David Escobar Sanabria; Jing Wang; Amy Pearson; Meghan Hill; Remi Patriat; Lauren E Schrock; Scott E Cooper; Michael C Park; Noam Harel; Michael J Howell; Colum D MacKinnon; Jerrold L Vitek; Luke A Johnson
Journal:  NPJ Parkinsons Dis       Date:  2022-09-12

4.  Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3.

Authors:  Maria-Efstratia Tsimpanouli; Anjesh Ghimire; Anna J Barget; Ridge Weston; Henry L Paulson; Maria do Carmo Costa; Brendon O Watson
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.